|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RAPID COMMUNICATIONS |
Center for Biomedical Engineering, Brown University, Providence, Rhode Island, USA
Key Words. Diabetes • Insulin • Embryonic stem cell • Glucose stimulation • Immunostaining
Correspondence: Hyun Joon Paek, Ph.D., Center for Biomedical Engineering, Brown University, Providence, Rhode Island, USA. Telephone: 401-863-3262; Fax: 401-863-1753; e-mail: Hyun_Paek{at}brown.edu
The source of insulin released from insulin-releasing cell clusters (IRCCs) differentiated from embryonic stem cells remains unclear. Rajagopal et al. have suggested that IRCCs do not synthesize but secrete insulin that had been absorbed from media during the multistep protocol. We report here further data relevant to this controversy. No radioisotopic labeling of insulin was observed when IRCCs were incubated in a medium containing 35S-cysteine. Less than 1% of the extra-cellular stoichiometric C-peptide equivalent to insulin was secreted during glucose stimulation. However, intracellular immunostaining and immunogold labeling were both positive for C-peptide. Finally, a mass balance calculation showed that simple equilibration of IRCCs by Fickian diffusion from media accounted for at most 4% of secreted insulin. These findings and further analysis of the results of others suggest that the mechanism of insulin secretion by IRCCs is a combination of sequestration and de novo synthesis.
This article has been cited by other articles:
![]() |
A. S. Boyd, D. C. Wu, Y. Higashi, and K. J. Wood A Comparison of Protocols Used to Generate Insulin-Producing Cell Clusters from Mouse Embryonic Stem Cells Stem Cells, May 1, 2008; 26(5): 1128 - 1137. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
